Scientific paper - Original scientific paper
Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines
Frontiers in Immunology, 9 (2018); 991. https://doi.org/10.3389/fimmu.2018.00991

Hiršl, Lea; Brizić, Ilija; Jenuš, Tina; Juranić Lisnić, Vanda; Reichel, Johanna Julia; Jurković, Slaven; Krmpotić, Astrid; Jonjić, Stipan

Cite this document

Hiršl, L., Brizić, I., Jenuš, T., Juranić Lisnić, V., Reichel, J. J., Jurković, S. ... Jonjić, S. (2018). Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines. Frontiers in Immunology, 9.. doi: 10.3389/fimmu.2018.00991

Hiršl, Lea, et al. "Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines." Frontiers in Immunology, vol. 9, 2018. https://doi.org/10.3389/fimmu.2018.00991

Hiršl, Lea, Ilija Brizić, Tina Jenuš, Vanda Juranić Lisnić, Johanna Julia Reichel, Slaven Jurković, Astrid Krmpotić and Stipan Jonjić. "Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines." Frontiers in Immunology 9 (2018). https://doi.org/10.3389/fimmu.2018.00991

Hiršl, L., et al. (2018) 'Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines', Frontiers in Immunology, 9. doi: 10.3389/fimmu.2018.00991

Hiršl L, Brizić I, Jenuš T, Juranić Lisnić V, Reichel JJ, Jurković S, and sur.. Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines. Frontiers in Immunology [Internet]. 2018 May 07 [cited 2022 August 13];9. doi: 10.3389/fimmu.2018.00991

L. Hiršl, et al., "Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines", Frontiers in Immunology, vol. 9, May 2018. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:653520. [Accessed: 13 August 2022]

Please login to the repository to save this object to your list.